Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Contraceptive Preference Among Women at Risk of HIV Acquisition in a Preparatory Screening Study for a Phase III Microbicide Trial in South Western Uganda

Contraceptive Preference Among Women at Risk of HIV Acquisition in a Preparatory Screening Study... Contraceptive preferences of women at risk for HIV acquisition are not well documented. We report on contraceptive choices among women residing in small townships in southwestern Uganda. This was part of preparatory efforts for recruitment into the Ring Study, a phase 3 microbicide trial, between July 2013 and October 2014. Clinicians provided contraceptives per a woman’s choice. HIV testing and screening for other sexually transmitted infections were done at first contact and at screening for the trial. Contraceptive choice was summarized by demographics and regression analysis to show factors associated with use of the injectable method. Of 6725 women contacted, 489 were prescreened. Of these 489 women, most (306, 63%) were already using contraception. Injectables were most preferred (58.7%), followed by implants (23.9%). Women living with a regular sexual partner preferred the injectable method (61.0%, P = 0.06), compared with other methods. Women at risk for HIV infection are willing to initiate use of modern contraceptives, which may reduce study dropout during intervention trials due to unintended pregnancy. Registration no: NCT01539226. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png AIDS and Behavior Springer Journals

Contraceptive Preference Among Women at Risk of HIV Acquisition in a Preparatory Screening Study for a Phase III Microbicide Trial in South Western Uganda

Download PDF
8 pages

Loading next page...
 
/lp/springer_journal/contraceptive-preference-among-women-at-risk-of-hiv-acquisition-in-a-MBU0eLf3AE
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Public Health; Health Psychology; Infectious Diseases
ISSN
1090-7165
eISSN
1573-3254
DOI
10.1007/s10461-018-2177-3
Publisher site
See Article on Publisher Site

Abstract

Contraceptive preferences of women at risk for HIV acquisition are not well documented. We report on contraceptive choices among women residing in small townships in southwestern Uganda. This was part of preparatory efforts for recruitment into the Ring Study, a phase 3 microbicide trial, between July 2013 and October 2014. Clinicians provided contraceptives per a woman’s choice. HIV testing and screening for other sexually transmitted infections were done at first contact and at screening for the trial. Contraceptive choice was summarized by demographics and regression analysis to show factors associated with use of the injectable method. Of 6725 women contacted, 489 were prescreened. Of these 489 women, most (306, 63%) were already using contraception. Injectables were most preferred (58.7%), followed by implants (23.9%). Women living with a regular sexual partner preferred the injectable method (61.0%, P = 0.06), compared with other methods. Women at risk for HIV infection are willing to initiate use of modern contraceptives, which may reduce study dropout during intervention trials due to unintended pregnancy. Registration no: NCT01539226.

Journal

AIDS and Behavior – Springer Journals

Published: May 31, 2018

References

  • Unintended pregnancy in sub-Saharan Africa: magnitude of the problem and potential role of contraceptive implants to alleviate it
    Hubacher, D; Mavranezouli, I; McGinn, E
  • Unintended pregnancy and induced abortion in Uganda: causes and consequences
    Singh, S; Moore, A; Bankole, A; Mirembe, F; Wulf, D
  • ‘We are despised in the hospitals’: sex workers’ experiences of accessing health care in four African countries
    Scorgie, F; Nakato, D; Harper, E
  • Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment services
    Kaida, A; Laher, F; Strathdee, SA
  • Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women
    Karim, QA; Karim, SSA; Frohlich, JA
  • Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western Uganda
    Abaasa, A; Gafos, M; Anywaine, Z
  • Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women
    Reid, SE; Dai, JY; Wang, J
  • Induced abortion, contraceptive use, and dual protection among female sex workers in Moscow, Russia
    Decker, MR; Yam, EA; Wirtz, AL
  • The need for family planning and safe abortion services among women sex workers seeking STI care in Cambodia
    Delvaux, T; Crabbe, F; Seng, S; Laga, M
  • Structural determinants of dual contraceptive use among female sex workers in Gulu, northern Uganda
    Erickson, M; Goldenberg, SM; Ajok, M; Muldoon, KA; Muzaaya, G; Shannon, K
  • Contextual influences on modern contraceptive use in sub-Saharan Africa
    Stephenson, R; Baschieri, A; Clements, S; Hennink, M; Madise, N
  • Trend in the use of modern contraception in sub-Saharan Africa: does women’s education matter?
    Emina, JB; Chirwa, T; Kandala, N-B
  • Pregnancy and contraceptive use among women participating in the FEM-PrEP trial
    Callahan, R; Nanda, K; Kapiga, S
  • Contraceptive use and pregnancy incidence among women participating in an HIV prevention trial
    Akello, CA; Bunge, KE; Nakabiito, C
  • Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial
    Sibeko, S; Baxter, C; Yende, N; Karim, QA; Karim, SSA
  • Hormonal contraception and HIV acquisition—what is the evidence? What are the policy and operational implications?
    Delvaux, T; Buve, A
  • Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis
    Morrison, CS; Chen, P-L; Kwok, C
  • Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
    Morrison, CS; Pai-Lien, C; Cynthia, K
  • Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women
    Nel, A; Niekerk, N; Kapiga, S
  • Prevalence proportion ratios: estimation and hypothesis testing
    Skove, T; Deddens, J; Petersen, MR; Endahl, L
  • The use of fractional polynomials to model continuous risk variables in epidemiology
    Royston, P; Ambler, G; Sauerbrei, W
  • What happens to contraceptive use after injectables are introduced? An analysis of 13 countries
    Sutherland, EG; Otterness, C; Janowitz, B
  • An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women
    Polis, CB; Curtis, KM; Hannaford, PC
  • Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence
    Polis, CB; Phillips, SJ; Curtis, KM
  • Acceptability of depot medroxyprogesterone in women attending general outpatient department: a cross sectional study
    Chaudhuri, S; Rai, B; Giri, R; Yadav, A; Giri, S
  • Trends in contraceptive practices among women in reproductive age at a health facility in Ghana: 2011–2013
    Amu, H; Nyarko, SH
  • Barriers to male involvement in contraceptive uptake and reproductive health services: a qualitative study of men and women’s perceptions in two rural districts in Uganda
    Kabagenyi, A; Jennings, L; Reid, A; Nalwadda, G; Ntozi, J; Atuyambe, L